Right ventricular endomyocardial fibrosis (2013 Grover Conference series)
- PMID: 25621149
- PMCID: PMC4278595
- DOI: 10.1086/676746
Right ventricular endomyocardial fibrosis (2013 Grover Conference series)
Abstract
Endomyocardial fibrosis (EMF) is a restrictive cardiomyopathy of unknown origin, affecting predominantly the right side of the heart. Its highest prevalence is in poor regions of sub-Saharan Africa, where it is usually found in children and adolescents. In areas where it is endemic, EMF is a major cause of heart failure and premature death. EMF of the right ventricle has unique clinical, electrocardiographic, and echocardiographic signs. Several features of advanced disease are not fully understood, the most striking being the presence of severe ascites with little or no pedal edema. Echocardiography is the main diagnostic tool and supports management of the disease in most patients, as it allows assessment of the severity and extension of endocardial fibrosis, the quality of the right atrioventricular valve, and the presence of intracardiac thrombi. Pulmonary hypertension in the setting of right EMF is related to chronic thromboembolism, through the chronic thrombi present in the severely enlarged right atrium found in advanced disease. The management of right EMF is difficult. Treatment of symptomatic patients should be surgical. However, as the disease is usually detected in late stages, with severe and advanced lesions, surgery cannot be performed without a very high risk of death and complications. New surgical approaches addressing several components of the structural cardiac abnormalities have been attempted, with promising results. EMF remains one of the most neglected diseases worldwide, and research into its pathophysiological mechanisms will probably improve outcomes and alter the natural history of the disease. This requires improvement in the health systems in areas of endemicity as well as the design of international collaborative research projects.
Keywords: endomyocardial fibrosis; pulmonary hypertension; sub-Saharan Africa.
Figures




Similar articles
-
Echocardiography accurately assesses the pathological abnormalities of chronic endomyocardial fibrosis.Int J Cardiovasc Imaging. 2011 Oct;27(7):955-64. doi: 10.1007/s10554-010-9753-6. Epub 2010 Nov 26. Int J Cardiovasc Imaging. 2011. PMID: 21110101
-
A case report of a 40-year-old woman with endomyocardial fibrosis in a non-tropical area: from initial presentation to high urgent heart transplantation.BMC Cardiovasc Disord. 2019 Dec 19;19(1):302. doi: 10.1186/s12872-019-1243-8. BMC Cardiovasc Disord. 2019. PMID: 31881943 Free PMC article.
-
Clinico-pathological evaluation of restrictive cardiomyopathy (endomyocardial fibrosis and idiopathic restrictive cardiomyopathy) in India.Eur J Heart Fail. 2004 Oct;6(6):723-9. doi: 10.1016/j.ejheart.2003.11.009. Eur J Heart Fail. 2004. PMID: 15542407
-
Tropical Endomyocardial Fibrosis: Natural History, Challenges, and Perspectives.Circulation. 2016 Jun 14;133(24):2503-15. doi: 10.1161/CIRCULATIONAHA.115.021178. Circulation. 2016. PMID: 27297343 Review.
-
Challenges in addressing the knowledge gap on endomyocardial fibrosis through community-based studies.Cardiovasc Diagn Ther. 2020 Apr;10(2):279-288. doi: 10.21037/cdt.2019.08.07. Cardiovasc Diagn Ther. 2020. PMID: 32420110 Free PMC article. Review.
Cited by
-
Endomyocardial fibrosis: recent advances and future therapeutic targets.Nat Rev Cardiol. 2025 Aug;22(8):564-576. doi: 10.1038/s41569-025-01138-x. Epub 2025 Feb 26. Nat Rev Cardiol. 2025. PMID: 40011660 Review.
-
Assessment of Right Ventricular Function-a State of the Art.Curr Heart Fail Rep. 2023 Jun;20(3):194-207. doi: 10.1007/s11897-023-00600-6. Epub 2023 Jun 5. Curr Heart Fail Rep. 2023. PMID: 37271771 Free PMC article. Review.
-
Challenges in pacing in right ventricular endomyocardial fibrosis: A case study.HeartRhythm Case Rep. 2023 Oct 13;10(1):11-14. doi: 10.1016/j.hrcr.2023.10.010. eCollection 2024 Jan. HeartRhythm Case Rep. 2023. PMID: 38264115 Free PMC article. No abstract available.
-
[Right ventricular endomyocardial fibrosis: Atypical presentation of a rare disease. Case report].Arch Peru Cardiol Cir Cardiovasc. 2024 Dec 11;5(4):243-248. doi: 10.47487/apcyccv.v5i4.409. eCollection 2024 Oct-Dec. Arch Peru Cardiol Cir Cardiovasc. 2024. PMID: 40401032 Free PMC article. Spanish.
-
Endomyocardial involvement in asymptomatic Latin American migrants with eosinophilia related to helminth infection: A pilot study.PLoS Negl Trop Dis. 2024 Aug 5;18(8):e0012410. doi: 10.1371/journal.pntd.0012410. eCollection 2024 Aug. PLoS Negl Trop Dis. 2024. PMID: 39102438 Free PMC article.
References
-
- Somers K. Restrictive cardiomyopathies. In Pongpanich B, Sueblinvong V, Vongprateep C, eds. Pediatric cardiology. International Congress Series 906. Amsterdam: Excerpta Medica, 1990.
-
- Yacoub S, Mocumbi AO, Yacoub MH. Neglected tropical cardiomyopathies: I. Chagas disease. Heart 2008;94(2):244–248. - PubMed
-
- Mocumbi A, Ferreira MB, Sidi D, Yacoub MH. A population study of endomyocardial fibrosis in a rural area of Mozambique. N Engl J Med 2008;359(1):43–49. - PubMed
-
- Mocumbi AO, Yacoub S, Yacoub MH. Neglected tropical cardiomyopathies: II. Endomyocardial fibrosis. Heart 2008;94(3):384–390. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources